New Results
RIPK3 inhibition prevents KRAS mutant p53 deficient lung tumor progression by impeding MDSCs
Asha Jayakumar
doi: https://doi.org/10.1101/853978
Asha Jayakumar
Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520
Article usage
Posted November 25, 2019.
RIPK3 inhibition prevents KRAS mutant p53 deficient lung tumor progression by impeding MDSCs
Asha Jayakumar
bioRxiv 853978; doi: https://doi.org/10.1101/853978
Subject Area
Subject Areas
- Biochemistry (11736)
- Bioengineering (8746)
- Bioinformatics (29186)
- Biophysics (14964)
- Cancer Biology (12084)
- Cell Biology (17401)
- Clinical Trials (138)
- Developmental Biology (9418)
- Ecology (14176)
- Epidemiology (2067)
- Evolutionary Biology (18299)
- Genetics (12235)
- Genomics (16793)
- Immunology (11863)
- Microbiology (28066)
- Molecular Biology (11580)
- Neuroscience (60925)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4956)
- Plant Biology (10422)
- Synthetic Biology (2883)
- Systems Biology (7338)
- Zoology (1650)